Literature DB >> 2442284

Protective immunogenicity and T lymphocyte specificity of a trivalent hybrid peptide containing NH2-terminal sequences of types 5, 6, and 24 M proteins synthesized in tandem.

E H Beachey, J M Seyer, J B Dale.   

Abstract

The protective immunogenicity of a hybrid peptide containing tandem copies of types 5, 6, and 24 M protein epitopes was investigated. An NH2-terminal peptide of type 24 M protein was chemically synthesized and then extended to include NH2-terminal peptides of types 6 and 5 M proteins yielding a 34-residue hybrid peptide containing a cysteine residue at its COOH-terminus. When conjugated via the cysteine residue to keyhole limpet hemocyanin (KLH), emulsified in CFA, and injected into rabbits, the synthetic hybrid evoked opsonic antibodies against types 5, 6, and 24 streptococci without stimulating tissue crossreactive immunity. The trivalent hybrid also was capable of priming T lymphocytes in vivo that responded to each of the native serotypes of M protein as well as to the synthetic hybrid peptide in vitro. The primed T cells failed to respond to the individual component peptides contained in the hybrid peptide, suggesting that the hybrid peptide confers conformations resembling the presentations of each of the subpeptides in the respective serotypes of M protein. The brisk immune responses to the type 6 peptide contained in the middle of the tandem hybrid indicates that with judicious placement between proline residues, potentially hidden peptides are readily accessible to the immune system. These results suggest that synthetic tandem peptides can be tailored in a fashion in which each of the component sets of protective epitopes can be made optimally immunoaccessible and immunogenic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442284      PMCID: PMC2188696          DOI: 10.1084/jem.166.3.647

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Primary structure of protective antigens of type 24 streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  J Biol Chem       Date:  1980-07-10       Impact factor: 5.157

2.  Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein.

Authors:  E H Beachey; J M Seyer; J B Dale; W A Simpson; A H Kang
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

3.  Repeating covalent structure of streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

4.  Streptococcal M protein: alpha-helical coiled-coil structure and arrangement on the cell surface.

Authors:  G N Phillips; P F Flicker; C Cohen; B N Manjula; V A Fischetti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci.

Authors:  E Whitnack; E H Beachey
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  Peptic digestion of streptococcal M protein. II. Extraction of M antigen from group A streptococci with pepsin.

Authors:  E H Beachey; G L Campbell; I Ofek
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

7.  Electron microscopic studies on streptococci. I. M antigen.

Authors:  J Swanson; K C Hsu; E C Gotschlich
Journal:  J Exp Med       Date:  1969-11-01       Impact factor: 14.307

8.  Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

9.  Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.

Authors:  E H Beachey; G H Stollerman; R H Johnson; I Ofek; A L Bisno
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen.

Authors:  E H Beachey; G H Stollerman; E Y Chiang; T M Chiang; J M Seyer; A H Kang
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

View more
  18 in total

1.  Identification of sequence types among the M-nontypeable group A streptococci.

Authors:  W A Relf; D R Martin; K S Sriprakash
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

2.  Domain structure and molecular flexibility of streptococcal M protein in situ probed by limited proteolysis.

Authors:  K M Khandke; T Fairwell; A S Acharya; B N Manjula
Journal:  J Protein Chem       Date:  1990-10

3.  The amino-terminal region of group A streptococcal M protein determines its molecular state of assembly and function.

Authors:  K M Khandke; T Fairwell; E H Braswell; B N Manjula
Journal:  J Protein Chem       Date:  1991-02

4.  Mapping T-cell epitopes in group A streptococcal type 5 M protein.

Authors:  J H Robinson; M C Atherton; J A Goodacre; M Pinkney; H Weightman; M A Kehoe
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 5.  Streptococcal M protein: molecular design and biological behavior.

Authors:  V A Fischetti
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

6.  Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.

Authors:  Jay A Spencer; Tom Penfound; Sanaz Salehi; Michelle P Aranha; Lauren E Wade; Rupesh Agarwal; Jeremy C Smith; James B Dale; Jerome Baudry
Journal:  Vaccine       Date:  2021-02-26       Impact factor: 3.641

Review 7.  Subdominance in Antibody Responses: Implications for Vaccine Development.

Authors:  Gunnar Lindahl
Journal:  Microbiol Mol Biol Rev       Date:  2020-11-25       Impact factor: 11.056

8.  Streptococcus pyogenes genes that promote pharyngitis in primates.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Andrew S Waller; Zhizeng Sun; Timothy Palzkill; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  JCI Insight       Date:  2020-06-04

9.  Streptococcal M6 protein binds to fucose-containing glycoproteins on cultured human epithelial cells.

Authors:  J R Wang; M W Stinson
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  Vimentin-cross-reactive epitope of type 12 streptococcal M protein.

Authors:  W Kraus; J M Seyer; E H Beachey
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.